SCHEMBL26599922

SCHEMBL26599922

C=Cc1ccccc1-c1cnccc1C(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ GLA P06280 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ KMT2A Q03164 1/20 0.44
▸ FGFR1 P11362 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ FGFR2 P21802 1/20 0.42
▸ FGFR4 P22455 1/20 0.42
▸ FGFR3 P22607 1/20 0.42
▸ SLC6A3 Q01959 4/20 0.40
▸ SLC6A4 P31645 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ HTT P42858 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31322070 0.84 SLC6A3 (0.51) KDM4EALDH1A1KMT2ASLC6A3SLC6A4
SCHEMBL31207927 0.83 KDM4C (0.44) KDM4EALDH1A1KMT2AL3MBTL1CCNC
SCHEMBL26600023 0.83 KDM4C (0.44) KDM4EALDH1A1KMT2AL3MBTL1CCNC
SCHEMBL19284336 0.81 KDM4E (0.58) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL31584153 0.81 KDM4E (0.58) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL21056662 0.80 KDM4E (0.54) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL31119793 0.79 SLC22A12 (0.56) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL22717408 0.79 SLC22A12 (0.56) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL31006669 0.79 SLC22A12 (0.56) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL22216857 0.78 KDM4E (0.54) KDM4EALDH1A1GLAGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023202623-A1 POLQ INHIBITOR COMPOUND AND USE THEREOF 南京再明医药有限公司 2023-10-26 — — WO disclosed
Send feedback